InVivo Therapeutics (NVIV.OB) Completes $13M Financing
InVivo Therapeutics Holdings Corp. is a medical device company focused on technology to develop treatments to improve function in individuals paralyzed as a result of traumatic spinal cord injury. The company today announced the completion of a private placement of 13 million units of its securities, generating proceeds of $13 million. Each unit sold consists of one share of common stock of InVivo and one warrant, with each warrant entitling the holder to purchase one share of common stock for a five-year period at an exercise price of $1.40 per share. If warrants issued in the private placement are exercised…